FDA Adverse Event Injury Summary report: N

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

MDR report key: 3231691 · Received July 17, 2013

Report

Report Number
1416980-2013-18756
Event Type
Injury
Date Received
July 17, 2013
Date of Event
June 21, 2013
Report Date
June 22, 2013
Manufacturer
BAXTER HEALTHCARE CORPORATION
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

COMPLAINT NO: (B)(4). THE CAUSE OF THIS PERITONITIS WAS USE ERROR REPORTED TO BE DUE TO A BREAK IN ASEPTIC TECHNIQUE BY THE PATIENT. PER BAXTER LABELING, USERS ARE INSTRUCTED TO USE ASEPTIC TECHNIQUE WHEN PERFORMING PERITONEAL DIALYSIS THERAPY. A FORMAL REVIEW OF THE LABEL FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION, A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT EXPERIENCED A BREAK IN ASEPTIC TECHNIQUE DURING PERITONEAL DIALYSIS (PD) THERAPY WHICH CAUSED PERITONITIS. ON AN UNREPORTED DATE, THERE WAS A BREAK IN ASEPTIC TECHNIQUE, FURTHER DESCRIBED AS THE ATTENDANT WAS DOING CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) WITHOUT PROPER TRAINING AND WAS NOT WEARING A MASK. SUBSEQUENTLY THE PATIENT EXPERIENCED PERITONITIS. ON AN UNREPORTED DATE, THE PATIENT WAS TREATED WITH INJECTION FORTUM (1GM, DAILY, IP) AND VANCOMYCIN (2GM, WEEKLY, IP) FOR PERITONITIS. AT THE TIME OF THIS REPORT, THE OUTCOME OF THE PERITONITIS WAS UNKNOWN AND DIANEAL THERAPY WAS ONGOING. ADDITIONAL INFORMATION WAS REQUESTED BUT IS NOT AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
331135 SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 58 YR Required Intervention EXTRANEAL| DIANEAL PD2 2.5% ULTRABAG